Fig 1.
Diagram describes the production of GRO-NPs@Pt-NPs by the PLAL technique.
(A) GRO-NPs; (B) Pt-NPs, (C) GRO@Pt-NPs, (D) purification by centrifugation, (E) the ratio% of GRO@Pt-NPs.
Fig 2.
UV-vis spectrum analysis of GRO-NPs, Pt-NPs, and GRO@Pt-NPs.
Fig 3.
TEM images and particle size distribution histograms for (A) GRO-NPs, (B) Pt-NPs, and (C) GRO@Pt-NPs.
Fig 4.
(A) EDX analysis for GRO-NPs showing EDX spot (B) and elemental mapping (C, D) of oxygen (O) and graphene (Gr), respectively.
Fig 5.
(A) EDX analysis for Pt-NPs showing EDX spot (B) and elemental mapping (C, D) of oxygen (O) and platinum (Pt), respectively.
Fig 6.
(A) EDX analysis for GRO@Pt-NPs showing EDX spot (B) and elemental mapping (C, D, E, F) of graphene (Gr), platinum (Pt), oxygen (O), iron (Fe), sulfur (S), and carbon (C), respectively.
Fig 7.
XRD analysis of Pt-NPs, GRO-NPs, and GRO@Pt-NPs.
Fig 8.
Inhibition zone of (A) GRO-NPs, (B) control negative D.W, (C) Pt-NPs, (D) GRO@Pt-NPs against E. faecium and K. pneumoniae. *p≤0.05, ** p≤0.01, *** p≤0.001.
Fig 9.
Reduces biofilm formation in K. pneumoniae, E. faecium.
(A) Control, (B) (Pt-NPs), (C) (GRO-NPs), and (D) (GRO@Pt-NPs) stained using crystal violet. *p≤0.05, ** p≤0.01, *** p≤0.001. Magnification power is 100 X.